Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents

(2019) C Macchi et al.   European Journal of Preventive Cardiology

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content

(2019) Yftach Gepner et al.   JOURNAL OF HEPATOLOGY

Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals

(2017) Bo Kobberø Lauridsen et al.   EUROPEAN HEART JOURNAL

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

(2017) P. Dongiovanni et al.   JOURNAL OF INTERNAL MEDICINE

Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases

(2017) Nima Motamed et al.   Clinics and Research in Hepatology and Gastroenterology

Liver fat accumulation is associated with circulating PCSK9

(2016) Massimiliano Ruscica et al.   ANNALS OF MEDICINE

Statin use and non-alcoholic steatohepatitis in at risk individuals

(2015) Paola Dongiovanni et al.   JOURNAL OF HEPATOLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease: What the clinician needs to know

(2014) Mariana Verdelho Machado   WORLD JOURNAL OF GASTROENTEROLOGY

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

(2012) Lokpal S. Bhatia et al.   EUROPEAN HEART JOURNAL